ARTICLE | Finance
Trio of Hong Kong listings raise $865M
July 10, 2020 1:21 AM UTC
Updated on Jul 10, 2020 at 7:22 PM UTC
Shenzhen Hepalink, the first among a trio of biotechs slated to begin trading on the Hong Kong stock exchange this week, posted a modest first-day dip.
Shenzhen Hepalink Pharmaceutical Group Co. Ltd. (SZSE:002399; HKEX:09989), which has been listed on the Shenzhen Stock Exchange since 2010, dropped HK$0.74 to HK$17.66 in its first day of trading in Hong Kong on Wednesday; it ended Thursday largely unchanged at HK$17.92...